- Home
- BODI vs RVPH Comparison
BODI vs RVPH Comparison
Compare BODI & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- RVPH
- Stock Information
- Founded
- BODI 1998
- RVPH 2006
- Country
- BODI United States
- RVPH United States
- Employees
- BODI N/A
- RVPH N/A
- Industry
- BODI Industrial Machinery/Components
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- BODI Industrials
- RVPH Health Care
- Exchange
- BODI Nasdaq
- RVPH Nasdaq
- Market Cap
- BODI 25.4M
- RVPH 26.6M
- IPO Year
- BODI N/A
- RVPH N/A
- Fundamental
- Price
- BODI $4.55
- RVPH $0.47
- Analyst Decision
- BODI Buy
- RVPH Strong Buy
- Analyst Count
- BODI 2
- RVPH 5
- Target Price
- BODI $10.00
- RVPH $9.00
- AVG Volume (30 Days)
- BODI 16.8K
- RVPH 3.2M
- Earning Date
- BODI 08-05-2025
- RVPH 08-13-2025
- Dividend Yield
- BODI N/A
- RVPH N/A
- EPS Growth
- BODI N/A
- RVPH N/A
- EPS
- BODI N/A
- RVPH N/A
- Revenue
- BODI $371,113,000.00
- RVPH N/A
- Revenue This Year
- BODI N/A
- RVPH N/A
- Revenue Next Year
- BODI N/A
- RVPH N/A
- P/E Ratio
- BODI N/A
- RVPH N/A
- Revenue Growth
- BODI N/A
- RVPH N/A
- 52 Week Low
- BODI $3.38
- RVPH $0.30
- 52 Week High
- BODI $8.71
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- BODI 60.10
- RVPH 45.52
- Support Level
- BODI $3.81
- RVPH $0.44
- Resistance Level
- BODI $4.79
- RVPH $0.53
- Average True Range (ATR)
- BODI 0.30
- RVPH 0.04
- MACD
- BODI 0.06
- RVPH 0.02
- Stochastic Oscillator
- BODI 62.73
- RVPH 49.00
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.